Show simple item record

dc.contributor.authorBİLGİNER, YELDA
dc.contributor.authorAyaz, Nuray
dc.contributor.authorCalguneri, Meral
dc.contributor.authorÖZEN, SEZA
dc.date.accessioned2021-03-03T19:16:34Z
dc.date.available2021-03-03T19:16:34Z
dc.date.issued2011
dc.identifier.citationÖZEN S., BİLGİNER Y., Ayaz N., Calguneri M., "Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine", JOURNAL OF RHEUMATOLOGY, cilt.38, sa.3, ss.516-518, 2011
dc.identifier.issn0315-162X
dc.identifier.otherav_53a60992-b208-4602-a3ae-0bfdefb9dde0
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/59286
dc.identifier.urihttps://doi.org/10.3899/jrheum.100718
dc.description.abstractObjective. Familial Mediterranean fever (FMF) is a recessively inherited autoinflammatory disorder characterized by recurrent attacks of fever and serositis. Although colchicine is the standard therapy for preventing attacks and suppressing inflammation, 5%-10% of compliant patients are colchicine-resistant. We report the effect of anti-tumor necrosis factor therapy (etanercept) and anti-interleukin 1 (IL-1) treatment (anakinra) in 6 cases resistant to colchicine therapy.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleAnti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine
dc.typeMakale
dc.relation.journalJOURNAL OF RHEUMATOLOGY
dc.contributor.departmentHacettepe Üniversitesi , Tıp Fakültesi (Türkçe) , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume38
dc.identifier.issue3
dc.identifier.startpage516
dc.identifier.endpage518
dc.contributor.firstauthorID838506


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record